Medical Advertising Hall of Fame seeks nominations

Share this article:

The Medical Advertising Hall of Fame (MAHF) is seeking nominations for its 2008 class as it looks to a newer generation of industry contributors as potential honorees.

“The award is an enshrinement,” MAHF chairperson Scott Cotherman told MM&M, “It recognizes the life-long contributions of people who have made a significant impact on our industry in a variety of different areas, those who have also provided great service to the industry outside of their specific responsibilites.”

Cotherman, who is also CEO of Corbett Accel, said, “As you look at MAHF what you have very often is the most well-known, the names on the door, the best of the best. But that's not going to be the obvious group of people going forward with this new generation. It really gives us an opportunity to showcase people who have made great contributions, those who may not be the names on the door, if you will.” 

The deadline for MAHF nominations is Aug. 31.

MAHF seeks candidates based on two primary criteria:

• The candidate's achievement as evidenced by impact on brand and corporate success, leadership of his or her company, accomplishments in the creative, marketing/research or publishing disciplines and innovations in the advertisng process or structure.

• The contributions the candidate has made to enhance the reputation of the medical advertising industry through voluntary efforts outside his or her company. The nominee's record of advertising and service must have been accomplished in the advertising industry in the United States or with an American company abroad. The candidate must have completed his or her primary career. The council of judges shall consider the election of either living or deceased persons.

For full details on documentation and other submission requirements, contact David Gideon at 561-237-6121, email him at david@mahf.com, or visit www.mahf.com.

 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...